Dr. Richard Gallagher, Professor of Clinical Psychiatry at New York Medical College and also a faculty member of the Columbia University Psychoanalytic Center, discusses best practices in treating schizophrenia. He describes marijuana use in patients with schizophrenia and its association with the illness.

Related Reading
(3R,5R)-5-(3-[11C]Methoxy-phenyl)-3-((R)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one.
Leung K, Donohue S. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2010.2010 Aug 6 [updated 2010 Oct 7].

Reduced Cortical Thickness as an Outcome of Differential Sensitivity to Environmental Risks in Schizophrenia.
Habets P, Marcelis M, Gronenschild E, Drukker M, Os JV; for G.R.O.U.P.. Biol Psychiatry. 2010 Oct 15.

Do patients think cannabis causes schizophrenia? – A qualitative study on the causal beliefs of cannabis using patients with schizophrenia.
Buadze A, Stohler R, Schulze B, Schaub M, Liebrenz M. Harm Reduct J. 2010 Sep 28;7:22.

Sponsored by The Doctor’s Channel